YM 511(148869-05-0)
- Name: YM 511
- Synonyms:YM 511; YM511 (pharmaceutical)
- Molecular Formula:C16H12 Br N5
- Molecular Weight:354.209
- CAS Registry Number:148869-05-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.148869-05-0 Benzonitrile,4-[[(4-bromophenyl)methyl]-4H-1,2,4-triazol-4-ylamino]-
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)] CAS No.148869-05-0 YM 511
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.148869-05-0 Benzonitrile,4-[[(4-bromophenyl)methyl]-4H-1,2,4-triazol-4-ylamino]-
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] CAS No.148869-05-0 YM 511
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:YM 511
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.148869-05-0 YM 511
Assay:鈮?9% by HPLC Package:inquiry Transportation:inquiry Application:YM 511 is a potent aromatase (CYP19) inhibitor (IC50 = 0.4 and 0.12 nM at rat ovary and human placenta cells, respectively) that weakly inhibits the synthesis of other steroid hormones. YM 511 dec...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 102280-52-4/4-methyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5-dihydro-1,3-oxazol-2-amine
- 3376-40-7/Benzylphenylhydroxylamine
- 56969-26-7/1-(4-methylphenyl)-4,5-dihydro-1H,3H-1,4-epoxy[1,4]oxazepino[4,3-a]benzimidazole
- 2802-19-9/3-ethoxy-17-hydroxy-6-(trifluoromethyl)pregna-3,5-diene-20-one acetate
- 121927-76-2/4H-1-Benzopyran-3-aceticacid, 2-[(1E)-1-bromo-2-carboxyethenyl]-5-hydroxy-7-(hydroxymethyl)-4-oxo-, a-methyl ester (9CI)
- 126262-27-9/(8aR)-7-(3,4-dimethoxyphenyl)-6-(4-methoxyphenyl)-1,2,3,5,8,8a-hexahydroindolizine
- 6966-30-9/ethyl N-acetyl-beta-oxophenylalaninate
- 69833-24-5/N-(3-methylbutyl)-N-phenylbutanamide
- 80844-54-8/dichloroplatinum(2+) (1,2-diphenylethane-1,2-diyl)diazanide
- 80724-82-9/(3beta,5alpha,16alpha)-16-fluoro-3-hydroxyandrostan-17-one
- 100524-52-5/2-(2-carbamimidoylsulfanylethylamino)ethylsulfanylmethanimidamide trih ydrobromide
- 72869-68-2/Glycerides, C9-11-branched, polymers with phthalic anhydride and trimethylolpropane
- 103667-46-5/3-Tyr-octreotide
- 538-71-6/Domiphen bromide
- 64684-78-2/Oxygenase,acetylaminofluorene 7-mono- (9CI)
- 221684-08-8/Benzoic acid,3-chloro-4,6-dihydroxy-5-methyl-2-[(1E)-1-methyl-1-propen-1-yl]-,3-hydroxy-2-methyl-5-[(1E)-1-methyl-1-propen-1-yl]phenyl ester
- 84522-03-2/2-Ethylhexyl dihydrogen phosphate, compound with morpholine (1:2)
- 157536-36-2/murayalactone
- 8060-63-7/sigmamycin
- 148869-05-0/YM 511
- 13287-92-8/N-octanoylglucosylamine
- 1540-85-8/Dehydrosafynol
- 64042-15-5/2-METHOXY-4-NITROAZOBENZENE
- 160492-58-0/Olean-12-ene-23,28-dioicacid, 3-hydroxy-, 28-(O-b-D-glucopyranosyl-(1®3)-O-[O-b-D-glucopyranosyl-(1®2)-b-D-glucopyranosyl-(1®6)]-b-D-glucopyranosyl) 23-[(2R)-2-hydroxypropyl] ester, (3b,4a)- (9CI)
- 1976-56-3/4,4-diphenyl-1-(piperidin-1-yl)but-3-en-2-ol
- 63307-18-6/[8-fluoro-2-(trifluoromethyl)quinolin-4-yl](piperidin-2-yl)methanol
- 14422-78-7/2-(diethylamino)naphthalene-1,4-dione
- 4928-25-0/N-[(9H-fluoren-9-ylmethoxy)carbonyl]-S-(2,4,6-trimethoxybenzyl)cysteine
- 36285-11-7/Raucaffrinoline
- 51170-87-7/N-(2,4-dichlorophenyl)-4,5-dihydro-3H-pyrrol-2-amine